SCHEMBL17065281

SCHEMBL17065281

C[C@H]([AsH2])C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3886696 0.73
SCHEMBL8717167 0.73
SCHEMBL23328 0.70
Tert-Butylamine SCHEMBL5014315 0.70 ALDH1A1 (0.50)
2,2,3-Trimethylbutane SCHEMBL4481319 0.67 ALDH1A1 (0.44)
2,2,3-Trimethylbutane SCHEMBL122284 0.67
SCHEMBL4963628 0.67
SCHEMBL3861719 0.65
SCHEMBL11298587 0.64 ALDH1A1 (0.31)
2,2,3-Trimethylbutane SCHEMBL30369120 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114124-A1 BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS PRINCIPIA BIOPHARMA, INC. (US) 2017-01-11 EP disclosed
WO-2015134210-A1 BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS PRINCIPIA BIOPHARMA, INC. (US) 2015-09-11 WO disclosed